Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Desensitization to Pertuzumab With a Positive Skin Test Result in a Mixed-Phenotype Hypersensitivity Reaction.

Journal of investigational allergology & clinical immunology - 22 Jul 2022

Lemus Calderón J A, Tapia de Pedro G, Marchan Martín E, Guzmán Rodriguez R, Cabañes Higuero M N, Senent Sánchez C J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Desensitization, Immunologic
Share to Drug Hypersensitivity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Skin Tests

Source

Identifiers

PMID: 34779772
DOI: 10.18176/jiaci.0761

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Desensitization to Pertuzumab With a Positive Skin Test Result in a Mixed-Phenotype Hypersensitivity Reaction.PMID 34779772Read ↗

Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.Semantic proximity Read ↗

Management of adverse reactions to biologic agents.Semantic proximity Read ↗

The Increasing Role of the Allergist in the Management of Infusion Reactions at the Oncology Day HospitalSemantic proximity Read ↗

A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents.Semantic proximity Read ↗

Classification of Drug Hypersensitivity into Allergic, p-i, and Pseudo-Allergic Forms.Semantic proximity Read ↗

Management of Hypersensitivity in Oncology Practice: Risk Stratification, Phenotypic Markers, and Desensitization ProtocolsSemantic proximity Read ↗

Sensitization phenotypes in immediate reactions to piperacillin-tazobactam.Semantic proximity Read ↗

Fatal infusion reaction to cetuximab: the need for predictive risk factors and safer patient selection.Semantic proximity Read ↗

Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: phenotypes, endotypes and management with desensitization.Semantic proximity Read ↗

Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization.Semantic proximity Read ↗

Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization.Semantic proximity Read ↗

Clinical Phenotype Transition in Pemphigus May Suggest Undertreatment with Rituximab: Findings from a Retrospective Single-Centre Analysis of Relapsed Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.